News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mylan (MYL) And The DOJ Can't Seem To Get On The Same Page



11/17/2016 7:08:03 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs
Mylan and the Department of Justice don't seem to be on the same page these days.

On October 7, Mylan said agreed to pay $465 million to the Department of Justice and other government agencies over the way it classified the EpiPen in the Medicaid Drug Rebate Program. In the past few months, lawmakers have been accusing Mylan of overcharging Medicaid.

Mylan repeated the figure when it reported third-quarter earnings on Nov. 9. During a conference call with analysts that day, the company said it is still working with the DOJ to finalize that settlement.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES